CClinicalTrials.gg
Not yet recruitingNCT07587736Updated May 14, 2026

The Role of Ultrasonographic Tracheal Measurements in Predicting Hypoxemia During Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration

An observational study in ENDOBRONCHIAL ULTRASOUND - TRANSBRONCHIAL NEEDLE ASPIRATION, Hypoxemia and Trachea, sponsored by Ankara Ataturk Sanatorium Training and Research Hospital. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-05-14.

Sponsored by Ankara Ataturk Sanatorium Training and Research Hospital · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
300
Ages
18 Years and older
Sex
All
01

Study summary

Bronchoscopic procedures performed under endobronchial ultrasound (EBUS) guidance are widely used minimally invasive diagnostic methods for the evaluation of mediastinal lymph nodes. Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration (EBUS-TBNA) is an indicated procedure for the diagnosis, staging, and histopathological characterization of primary or metastatic tumors. The procedure is generally performed under moderate or deep sedation to enhance patient comfort and optimize procedural success. Deep sedation has been shown to be a safe and effective approach in terms of respiratory complications in both younger and elderly patients.

However, hypoxemia may develop during EBUS procedures due to mechanisms such as mechanical airway obstruction, sedation-related ventilatory depression, and ventilation-perfusion mismatch. A decrease in oxygen saturation is frequently observed during bronchoscopic procedures, with reported rates of up to 94%. Studies have also reported a hypoxemia rate of approximately 25% during EBUS, even with the use of a nasopharyngeal oxygen cannula. Therefore, maintaining adequate oxygenation throughout the procedure is of critical importance. In patients receiving sedation under spontaneous respiration, oxygen support is typically provided via low-flow systems such as nasal cannulae, which can generally deliver flows of up to 15 L/min.

It has been reported that a fiberoptic bronchoscope occupies approximately 10% of the tracheal cross-sectional area and about 15% at the level of the cricoid ring, leading to partial obstruction. EBUS endoscopes have a larger outer diameter and, in addition, may exert more pronounced negative effects on respiratory mechanics due to the balloon mechanism used. The outer diameter of EBUS bronchoscopes typically ranges between 6.2 and 6.7 mm, mechanically occupying a significant portion of the tracheal lumen. This may restrict tracheal airflow, leading to partial obstruction and consequently predisposing to hypoxemia. Therefore, identifying objective anatomical predictors that can predict the development of hypoxemia is of clinical importance. However, to the best of our knowledge, no study in the literature has statistically investigated the relationship between tracheal measurements and hypoxemia occurring during EBUS.

In this study, the investigators aim to investigate the relationship between pre-procedural tracheal diameter measured by ultrasonography (USG) and the EBUS outer diameter/tracheal diameter ratio (airway occupancy ratio) with the development of hypoxemia during the procedure in patients undergoing EBUS-TBNA. Additionally, it is aimed to determine the optimal tracheal diameter cutoff value that may predict the development of hypoxemia.

Study Design and Patient Population This study will be conducted in accordance with the Declaration of Helsinki and will be carried out at SBÜ Ankara Atatürk Sanatoryum Training and Research Hospital after obtaining approval from the institutional ethics committee. The study is planned as a prospective observational cohort study. Adult patients scheduled to undergo EBUS-TBNA will be included.

The following parameters will be recorded:

  • Age
  • Sex
  • Body mass index (BMI)
  • FEV1 value
  • Baseline SpO₂
  • Lowest recorded SpO₂
  • Systolic/diastolic/mean arterial blood pressure and heart rate measured at 10-minute intervals during the procedure
  • Sedative drug doses
  • Procedure duration
  • Tracheal diameter measured by ultrasonography (USG)
  • Airway occupancy ratio (EBUS outer diameter / narrowest tracheal diameter measured by USG)
  • Duration and total number of hypoxic episodes during the procedure
  • Requirement for airway interventions (jaw thrust, mask ventilation, intubation, etc.)
  • Whether nasal oxygen flow was increased in case of hypoxemia, and if so, by how many L/min
  • Presence of cough, hiccups, secretions requiring aspiration, bronchospasm, and procedure-related bleeding
  • Whether the procedure was interrupted
Read the detailed description

H0: There is no significant association between ultrasonographic tracheal measurements and the development of hypoxemia during Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration (EBUS-TBNA).

H1: There is a significant association between ultrasonographic tracheal measurements and the development of hypoxemia during Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration (EBUS-TBNA).

Ultrasonographic Measurements In this study, tracheal diameter will be measured using a high-frequency linear probe while the patient is in the supine position with the neck in a neutral position. Patients will be instructed to take a deep inspiration, and measurements will be obtained during inspiration at the level just below the cricoid cartilage and at the level of the 2nd-3rd tracheal rings. The narrowest transverse tracheal diameter will be recorded. All ultrasonographic measurements will be performed by the same anesthesiologist.

Sedation Protocol Patients will receive 4 L/min oxygen via nasal cannula along with routine hemodynamic monitoring. Sedation will be administered according to the standard protocol routinely used in our clinic. During the procedure, patients will be maintained under deep sedation corresponding to a Richmond Agitation-Sedation Scale (RASS) score of -4. The total doses of sedative agents used will be recorded.

02

Conditions studied

  • ENDOBRONCHIAL ULTRASOUND - TRANSBRONCHIAL NEEDLE ASPIRATION
  • Hypoxemia
  • Trachea

Keywords

  • ENDOBRONCHIAL ULTRASOUND
  • TRANSBRONCHIAL NEEDLE ASPIRATION
  • TRACHEAL DIAMETER
  • HYPOXEMİA
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

This study will be conducted in accordance with the Declaration of Helsinki and will be carried out at SBÜ Ankara Atatürk Sanatoryum Training and Research Hospital. In patients aged 18 years and older scheduled to undergo EBUS-TBNA, the narrowest pre-procedural tracheal diameter will be determined. The relationship between tracheal diameter and the development of hypoxemia will be analyzed.

Inclusion criteria

  • Patients scheduled for elective EBUS-TBNA
  • Patients who provide written informed consent
  • Patients with ASA physical status I-III
  • Patients aged ≥18 years

Exclusion criteria

Exclusion Criteria:

  • Tracheal stenosis or significant airway obstruction
  • History of tracheostomy
  • Use of home oxygen therapy
  • Pre-procedural SpO₂ \< 90% on room air
  • History of prior thoracic surgery
  • Diagnosis of congestive heart failure
  • Presence of pleural effusion
  • FEV1 \< 40%
  • COPD patients classified as GOLD stage 3-4
  • Restrictive lung disease (FVC \< 50%)
  • Advanced pulmonary hypertension
  • History of surgery affecting neck anatomy
  • Tracheal deviation due to large thyroid or mediastinal mass
  • ASA physical status IV
  • Pregnancy
  • EBUS performed under general anesthesia (with endotracheal intubation or laryngeal mask airway)
  • Hemodynamic instability
04

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
300 participants (estimated)
Patient registry
No

Groups and cohorts

  • Adult patients scheduled to undergo EBUS-TBNA

    "In patients aged 18 years and older scheduled to undergo EBUS-TBNA, the narrowest pre-procedural tracheal diameter will be determined. The relationship between tracheal diameter and the development of hypoxemia will be analyzed.

    Other: TRACHEAL DIAMETER MEASUREMENT · Other: Hypoxemia

Interventions

  • OtherTRACHEAL DIAMETER MEASUREMENT

    "In patients aged 18 years and older scheduled to undergo EBUS-TBNA, the narrowest pre-procedural tracheal diameter will be determined. The relationship between tracheal diameter and the development of hypoxemia will be analyzed.

  • OtherHypoxemia

    Hypoxemia will be defined as the presence of at least one of the following criteria: * SpO₂ \< 90% for at least 10 seconds, or * A decrease in SpO₂ of ≥5% from baseline

05

What researchers measure

Primary outcomes

  1. Hypoxemia

    Time frame: Periprocedural

06

Study locations

1 site
  • Ankara Ataturk Sanatorium Training and Research Hospital, Ankara, 06280
    Ankara, Turkey (Türkiye)
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT07587736
Lead sponsor
Ankara Ataturk Sanatorium Training and Research Hospital
Responsible party
Ramazan Baldemir (Clinic Associate Professor, Ankara Ataturk Sanatorium Training and Research Hospital) — Principal investigator
First posted
May 14, 2026
Start date
May 20, 2026 (estimated)
Primary completion
May 1, 2027 (estimated)
Completion
May 1, 2027 (estimated)
Last update
May 14, 2026

Study contacts

Ramazan BALDEMİR
Contact
baldemir2323@gmail.com
+905303570166
Ramazan BALDEMİR
principal investigator · ANKARA ATATURK SANATORİUM TRAİNİNG AND RESEARCH HOSPITAL

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion